SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients.

ABSTRACT:

Objective

The clinical implications of SARS-CoV-2 RNA viremia in blood (RNAemia) remain uncertain despite gaining more prognostic implications for coronavirus disease 2019 (COVID-19). However, the clinical relevance of SARS-CoV-2 RNAemia has not been well documented.

Methods

We conducted a cohort study on 95 confirmed COVID-19 patients and explored the prospects with evidence of SARS-CoV-2 RNAemia in association with various clinical characteristics. We performed reverse transcription-polymerase chain reaction and studied the risk factors of SARS-CoV-2 RNAemia using logistic regression analysis.

Results

The presence of SARS-CoV-2 RNAemia in critical or fatal cases was the highest (66.7%), followed by severe (12.5%) and mild to moderate (1.7%) in admission samples. SAR

SUBMITTER: Lawrence Panchali MJ 

PROVIDER: S-EPMC10386401 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature